Chemours
418 hedge funds and large institutions have $2.44B invested in Chemours in 2024 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 125 increasing their positions, 114 reducing their positions, and 76 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
418
Holders Change
-16
Holders Change %
-3.69%
% of All Funds
6.05%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
62
Increased
125
Reduced
114
Closed
76
Calls
$38M
Puts
$27.8M
Net Calls
+$10.2M
Net Calls Change
+$11.8M
Top Buyers
| 1 |
AWAM
Appian Way Asset Management
New York
|
+$34.2M |
| 2 |
VOMP
Vision One Management Partners
Miami,
Florida
|
+$28.3M |
| 3 |
Millennium Management
New York
|
+$24.2M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$13.7M |
| 5 |
SCM
Scopia Capital Management
New York
|
+$13.6M |
Top Sellers
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$19.7M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$18M |
| 3 |
JPMorgan Chase & Co
New York
|
-$13.4M |
| 4 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$13.4M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$7.04M |
